Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prevalence of retinopathy in prediabetes: A systematic review.
Kirthi V, Nderitu P, Alam U, Evans JR, Nevitt S, Malik RA, Hopkins D, Jackson TL. Kirthi V, et al. Among authors: hopkins d. Surv Ophthalmol. 2022 Sep-Oct;67(5):1332-1345. doi: 10.1016/j.survophthal.2022.04.002. Epub 2022 Apr 14. Surv Ophthalmol. 2022. PMID: 35430245 Review.
Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes, challenging the diagnostic threshold of diabetes.
Kirthi V, Reed KI, Alattar K, Zuckerman BP, Bunce C, Nderitu P, Alam U, Clarke B, Hau S, Al-Shibani F, Petropoulos IN, Malik RA, Pissas T, Bergeles C, Vas P, Hopkins D, Jackson TL. Kirthi V, et al. Among authors: hopkins d. Diabet Med. 2023 Mar;40(3):e14952. doi: 10.1111/dme.14952. Epub 2022 Sep 12. Diabet Med. 2023. PMID: 36054221 Free PMC article.
Effect of socioeconomic deprivation as determined by the English deprivation deciles on the progression of diabetic retinopathy and maculopathy: a multivariate case-control analysis of 88 910 patients attending a South-East London diabetic eye screening service.
Giannakis P, Nderitu P, Nunez do Rio JM, Webster L, Mann S, Hopkins D, Cardoso MJ, Modat M, Bergeles C, Jackson TL. Giannakis P, et al. Among authors: hopkins d. Br J Ophthalmol. 2024 May 21;108(5):747-752. doi: 10.1136/bjo-2023-323402. Br J Ophthalmol. 2024. PMID: 37380352
Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial.
Sivaprasad S, Prevost AT, Bainbridge J, Edwards RT, Hopkins D, Kelly J, Luthert P, Murphy C, Ramu J, Sarafraz-Shekary N, Vasconcelos J, White-Alao B, Hykin P. Sivaprasad S, et al. Among authors: hopkins d. BMJ Open. 2015 Sep 14;5(9):e008405. doi: 10.1136/bmjopen-2015-008405. BMJ Open. 2015. PMID: 26369798 Free PMC article. Clinical Trial.
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.
Sivaprasad S, Prevost AT, Vasconcelos JC, Riddell A, Murphy C, Kelly J, Bainbridge J, Tudor-Edwards R, Hopkins D, Hykin P; CLARITY Study Group. Sivaprasad S, et al. Among authors: hopkins d. Lancet. 2017 Jun 3;389(10085):2193-2203. doi: 10.1016/S0140-6736(17)31193-5. Epub 2017 May 7. Lancet. 2017. PMID: 28494920 Free article. Clinical Trial.
1,166 results